Baseline serum IL-17 also correlates with occurrence of colitis/diarrhoea in CPI recipients receiving anti-CTLA-4 (53) and was elevated in CPI-colitis patients compared to CPI patients who did not have an irAE (54). This evidence concerns the gene IL17A and colitis.